Donald Kellerman joins MAP Pharmaceuticals
This article was originally published in Scrip
Executive Summary
MAP Pharmaceuticals(US) has appointed Dr Donald Kellerman senior vice-president of clinical development and medical affairs. Most recently, Dr Kellerman was senior vice-president of development at Inspire Pharmaceuticals, where he was responsible for drug development, including clinical research, regulatory affairs, project management and biostatistics.